Follow
Wesley S. van de Geer
Wesley S. van de Geer
Erasmus MC
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Paneth cells respond to inflammation and contribute to tissue regeneration by acquiring stem-like features through SCF/c-Kit signaling
M Schmitt, M Schewe, A Sacchetti, D Feijtel, WS van de Geer, ...
Cell reports 24 (9), 2312-2328. e7, 2018
2042018
Evaluation of AXIN1 and AXIN2 as targets of tankyrase inhibition in hepatocellular carcinoma cell lines
W Wang, P Liu, M Lavrijsen, S Li, R Zhang, S Li, WS van de Geer, ...
Scientific Reports 11 (1), 7470, 2021
112021
Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer
L Mout, ME van Royen, C de Ridder, D Stuurman, WS van de Geer, ...
EBioMedicine 73, 2021
82021
CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue
J van Riet, C Saha, N Strepis, RWW Brouwer, ES Martens-Uzunova, ...
Communications Biology 5 (1), 338, 2022
72022
Paneth cells respond to inflammation and contribute to tissue regeneration by acquiring stem-like features through SCF/c-Kit signaling. Cell Rep. 2018; 24 (9): 2312–28
M Schmitt, M Schewe, A Sacchetti, D Feijtel, WS van de Geer, ...
J. CELREP 85, 2018
72018
ProteoDisco: a flexible R approach to generate customized protein databases for extended search space of novel and variant proteins in proteogenomic studies
WS van de Geer, J van Riet, HJG van de Werken
Bioinformatics 38 (5), 1437-1439, 2022
42022
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomas
WS van de Geer, Y Hoogstrate, K Draaisma, PA Robe, S Bins, ...
Neuro-Oncology Advances 4 (1), vdab177, 2022
42022
The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies
K de Joode, WS van de Geer, G van Leenders, P Hamberg, ...
Scientific reports 13 (1), 10720, 2023
12023
Identifying somatic changes in drug transporters using whole genome and transcriptome sequencing data of advanced tumors
WS van de Geer, RHJ Mathijssen, J van Riet, N Steeghs, M Labots, ...
Biomedicine & Pharmacotherapy 159, 114210, 2023
12023
31P Genomic landscape and actionable targets as identified by whole genome sequencing and RNA sequencing in patients with advanced renal cell carcinoma
KD Joode, WS van de Geer, G van Leenders, P Hamberg, HM Westgeest, ...
Annals of Oncology 32, S1386, 2021
2021
Comprehensive pan-cancer analysis of somatic mutations in drug transporters to reveal acquired and intrinsic drug resistance in 3149 metastatic cancer patients
S Bins, WS van de Geer, J van Riet, N Steeghs, HMW Verheul, ...
Annals of Oncology 30, v28-v29, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–11